UPM Raflatac has added new pharma security label materials to its labelling solutions portfolio. Credit: UPM.

Pressure-sensitive labelling solutions supplier UPM Raflatac has added new pharma security label materials to its labelling solutions portfolio.

The new solutions are designed to support pharmaceutical companies and enable them to enhance patient safety through secure packaging solutions.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The range features tamper-evident adhesives such as Red Luminescent solution with RP62 EU.

It can be used on existing machines to verify labels for 100% accuracy and glows red when illuminated by the sensor’s UV light.

Leveraging the company’s pharmaceutical adhesive RP62EU, the new solution offers a range of tamper-verification safety features enabling companies to identify visible, irreversible damage or change to the packaging or label when removed. It also provides holographic effects for packaging.

“Our newly expanded range of pharma security labelling materials offers simple implementation with a combination of effective tamper-verification solutions.”

UPM Raflatac EMEIA Pharma segment manager Markku Pietarinen said: “At UPM Raflatac, we focus our material development on the needs of the industry, anticipating legislative change and pre-empting market demand.

“Our newly expanded range of pharma security labelling materials offers simple implementation with a combination of effective tamper-verification solutions that blend seamlessly with existing packaging designs. Together, we are labelling a smarter future.”

The packaging firm noted that companies can achieve full compliance with the EU Falsified Medicines Directive on packaging for prescription drugs and over-the-counter (OTC) medicines by using the labelling solution.

UPM Raflatac produces self-adhesive label materials such as paper and film label stock for consumer product and industrial labelling applications.